drug induced ANCA associated vasculitis #ACR17 pic.twitter.com/3N7La0WS5x
— Suleman Bhana, MD (@DrBhana) November 4, 2017
Big Take Home Message from #ACR17 on influenza vaccination- AT Next MTX FUV- give the flu vaccine AND HOLD MTX for 2 weeks (Plenary Session) by Park et al. https://t.co/grfLQx0CYN pic.twitter.com/A3xOyZOu5m
— Dr. John Cush (@RheumNow) November 9, 2017
Big Take Home Message from #ACR17 on influenza vaccination- AT Next MTX FUV- give the flu vaccine AND HOLD MTX for 2 weeks (Plenary Session) by Park et al. https://t.co/grfLQx0CYN pic.twitter.com/A3xOyZOu5m
— Dr. John Cush (@RheumNow) November 9, 2017
#GAMECHANGER. Failure of RA guidelines. 67% of MTX mono fail. Combo DMARDs or scMTX is better #acr17 @rheumnow #443 pic.twitter.com/q4P0fk460V
— Janet (@Janetbirdope) November 8, 2017
No difference in lung safety of Abatacept and TNFI and one study of more ILD with IFX vs ABA #137. #acr17 @rheumnow #526 pic.twitter.com/ugYBF7THKa
— Janet (@Janetbirdope) November 8, 2017
#GAMECHANGER. Steroids cost more in rheumatic diseases; dose dependent Limit or reduce dose. #acr17 @rheumnow #1801
— Janet (@Janetbirdope) November 8, 2017
#GAMECHANGER. Pts with early RA value pain control which is improving over recent years. #acr17 @rheumnow #2955 pic.twitter.com/PVPEqgavDY
— Janet (@Janetbirdope) November 8, 2017
#ACR17 Rheumatology Roundup.Cush #11L biologics #2 CA; #1175 biologics infants; #141 Refractory RA; #1885 Epi of AOSD; #200 Gout Telemedicine ; #885 Voclosporin SLE GN. AKavanaugh #271 CD318; #1205 XRT OA? #661 Entheses; #1112 Pred Gout; #541 SIE; #2031 EMR labs; #144 MVA RA
— Dr. John Cush (@RheumNow) November 8, 2017
Steroid tapering/discontinuation suggestions in JDM, ? best predictors of clinical remission. #ACR17 @RheumNow #2956 https://t.co/U7UQTD1hnj pic.twitter.com/shk6fOThlh
— Dr. Rachel Tate (@uptoTate) November 8, 2017
Rheum Rockstars playing to a packed house! Thanks @RheumNow and Dr. K you are a highlight of #ACR17 #RheumRoundUp pic.twitter.com/8MpdYgdutV
— Donna Hoyne (@donna_hoyne) November 8, 2017
Treatment strategies for sarcoidosis: Baughman Grutters lancet 2015 #ACR17 pic.twitter.com/K4C9jCxj10
— Suleman Bhana, MD (@DrBhana) November 7, 2017
Excellent, methotrexate is not and strong trend towards being protective #ACR17 https://t.co/rYfcPLFzgh
— Richard Conway (@RichardPAConway) November 7, 2017
HCQ screening recommendations from the American Academy of ophthalmology #2016revision#ACR17 #HCQ#reviewcourse pic.twitter.com/iXwWD83OTM
— V. Ocampo D (@VOD_MD) November 4, 2017
Concluding remarks in #sarcoidosis treatment #acr17 pic.twitter.com/nPSKyb1ySi
— Christian Ammitzbøll (@cgytz) November 7, 2017
Vere low incidence of HCQ maculopathy/No blindness seen in large pt cohort
L8#ACR17 @RheumNow pic.twitter.com/H12ebizr9L— Julio Gonzalez (@japaoli19) November 7, 2017
Improvement and steroid reduction in CANDLE / SAVI patients treated with baricitinib @RheumNow #ACR17 #2758
— Ian N Bruce (@Lupusdoc) November 7, 2017
Addition of Steroid Rx to bDMARDs increases risk of post op infections. Effect dose depended #ACR17 #2755 @RheumNow pic.twitter.com/gELV2IriLc
— Olga Petryna (@DrPetryna) November 7, 2017
Good news for HCQ: still appears that clinically significant toxicity remains rare. #ACR17 @RheumNow #8L pic.twitter.com/04wLgCj07m
— Dr. Paul Sufka (@psufka) November 7, 2017
New real life treatment strategies for Systemic Sclerosis. I love MMF too! 👍 #ACR17 @RheumNow pic.twitter.com/M88uJZS097
— Philip Robinson (@philipcrobinson) November 7, 2017
New Jak-1 selective inhibitor ABT-494 doesn’t look too bad #ACR17 @RheumNow pic.twitter.com/sAHVqJr31a
— Philip Robinson (@philipcrobinson) November 7, 2017
Plenary #2754 tailored RTX based on +ANCA +CD19 B cells performed as well as scheduled RTX for AAV #ACR17 @rheumnow
— k dao (@KDAO2011) November 7, 2017
Despite new guidelines to limit HCQ to <5mg/kg, we still have patients on higher doses (esp women) #ACR17 @RheumNow #2034 pic.twitter.com/yRZSSoxIA7
— Dr. Paul Sufka (@psufka) November 7, 2017
Serious infections in RA more associated with disease activity than DMARDs/biologics. #ACR17 @RheumNow #2410 pic.twitter.com/rq050WvnPJ
— Dr. Paul Sufka (@psufka) November 7, 2017
#16L #acr17 no risk of DVTorPE w/Tofa from RTC trials analysis. IRs comparable to #corona data for Tofa&cDMARDs @RheumNow pic.twitter.com/7Z2LclfE5m
— Olga Petryna (@DrPetryna) November 7, 2017
IA STEROID for knee OA 2017 rct. Has not stopped me using occ steroid injection for the person in need #acr17 @RheumNow pic.twitter.com/3fNUuwND20
— Dr Irwin Lim (@_connectedcare) November 7, 2017
#2453 #acr17 no difference in disease activity&PRO with ADA after MTX d/c at 6mo:LDA 42%ADAvs40%ADA+MTX @RheumNow pic.twitter.com/EtxpmVAQyL
— Olga Petryna (@DrPetryna) November 7, 2017
Dr. Mease presenting late breaking abstract 17L on secukinumab and delaying radiographic progression in PsA. #ACR17 @rheumnow pic.twitter.com/jhuiT97P2i
— Dr. Rachel Tate (@uptoTate) November 7, 2017
The Great Debate at #ACR17. Detailed summary for those who missed it @RheumNow https://t.co/gV3haLAYLg
— Dr Irwin Lim (@_connectedcare) November 7, 2017
Dr. Olga Petryna: Cardiovascular Comorbidities
Dr. Ken Saag: Update on Gout Therapy
Summary of GCA therapy session and a few pearls. acr2017 @rheumnow pic.twitter.com/0Wglvf0OBF
— William Shergy (@WShergy) November 7, 2017
#1206
Another study showing the benefits of chondroitin sulfate in knee OA. 800mg dose.#ACR17 @RheumNow pic.twitter.com/Y61JgarcQV— Julio Gonzalez (@japaoli19) November 6, 2017
Mentor and mentee interview! Dr. J. Cush and Dr. T. Pincus. One of the best parts of #ACR17 is camaraderie! @rheumnow pic.twitter.com/gUlCnauWcc
— Dr. Rachel Tate (@DrRachelTate) November 6, 2017
Plenary abst#1788 examined intra-art steroid injection. Using OAI study, steroid use signif increases risk of knee OA progression & TKR #ACR pic.twitter.com/eTp4l68mo0
— Dr. John Cush (@RheumNow) November 6, 2017
Oral corticosteroids increase risk of preterm birth in all trimesters (regardless DMARD exposure)#ACR17 @rheumnow #1313
— Dr. Paul Sufka (@psufka) November 6, 2017
Higher risk of knee radiographic OA progression in pts treated with intra-articular steroids. #ACR17 @RheumNow #1788 https://t.co/ejl223fJ07 pic.twitter.com/dxewZHHbIJ
— Dr. Rachel Tate (@DrRachelTate) November 6, 2017
Seoul RCT: MTX discontinuation for 2 weeks after flu vaccine increased satisfactory vaccine response. No difference in flares #ACR17 #RA pic.twitter.com/6b4i01KjI4
— Trudy Taylor (@HalifaxRheum) November 5, 2017
Treatment of IRAEs has really been steroids & a few other Dmards #ACR17 @rheumnow pic.twitter.com/mzHoYHAPRt
— Dr Irwin Lim (@_connectedcare) November 5, 2017
Novel Anti-CD40 monoclonal ab CFZ533 potential benefit in Sjogren's Syndrome. #ACR17 @RheumNow #1784 https://t.co/sehIStKFM1
— Dr. Rachel Tate (@DrRachelTate) November 6, 2017
FDA issues strong warnings: no codeine/tramadol during pregnancy/breastfeeding due to risk to infants #ACR17 @rheumnow pic.twitter.com/qIap9J3C2L
— k dao (@KDAO2011) November 6, 2017
CMV and herpes zoster appear to have an increased risk in JAK inhibitors- other opportunistic infections also reported #acr17 c/o Winthrop pic.twitter.com/NRcskpfGlx
— ARD (@ARD_BMJ) November 6, 2017
Large trial, long fu. Celecoxib does NOT cause more CVS issues than Naproxen or Ibuprofen #ACR17 @rheumnow pic.twitter.com/mszgPO3P0D
— Dr Irwin Lim (@_connectedcare) November 5, 2017